Home | Structured Search | Drug Resource
Find: within
Posttraumatic Stress Disorder > Prevention Author: Jeffrey P. Staab, MD, MS
Editorial changes - 2008-07-29
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up

Tables
References
Glossary
What's New
Patient Information
Additional Resources
Tools

Rationale:

  • Although crisis debriefing interventions are now popular for individuals who have experienced a traumatic stress, they do not reduce acute symptoms, nor do they prevent the development of PTSD.

Evidence:

  • A recent meta-analysis found a statistically nonsignificant increase in PTSD rates after debriefing (RR, 1.33 [CI, 0.75 to 2.37]) (5).
  • An expert panel recently reviewed all data on the efficacy of crisis debriefing interventions. Interventions that include single-session recounting of the event seemed to do more harm than good (i.e., they increased symptoms) (6).

Comments:

  • Concepts of acute interventions developed in the 1990s have failed to show benefits in recent studies.

FAQs
Jeffrey P. Staab, MD, MS, is a consultant for Eli Lilly, Forest Laboratories, received honorarium from Abbott Laboratories, received grants from GlaxoSmithKline, Pfizer. Michael Roy, MD, editorial consultant, received honorarium from PFizer.


The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2008 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.